Surgical Science Sweden AB (publ) (STO: SUS)

SUS Revenue

Surgical Science Sweden AB had revenue of 231.83M SEK in the quarter ending September 30, 2024, with 10.27% growth. This brings the company's revenue in the last twelve months to 859.83M, down -5.06% year-over-year. In the year 2023, Surgical Science Sweden AB had annual revenue of 882.85M with 10.01% growth.

• Revenue (ttm): 859.83M
• Revenue Growth: -5.06%
• P/S Ratio: 8.70
• Revenue / Employee: 3.18M
• Employees: 260
• Market Cap: 7.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	882.85M	80.31M	10.01%
Dec 31, 2022	802.54M	435.76M	118.81%
Dec 31, 2021	366.78M	261.98M	249.98%
Dec 31, 2020	104.80M	3.28M	3.23%
Dec 31, 2019	101.52M	35.82M	54.51%